Andere Sprachen Arcellx, Inc.

Aktien

A3DEJC

US03940C1009

ACLX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 28.05.2024			% 5 Tage	% 1. Jan.
51,3 ^USD	-1,16 %		-3,70 %	-7,57 %

15.05.	ARCELLX, INC. : Stifel Nicolaus bleibt bei seiner Kaufempfehlung	ZM
14.05.	ARCELLX, INC. : Bewertung von Evercore ISI zum Kaufen erhalten	ZM

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Arcellx : IMMagine-3 Multi-center, Global, Phase 3 Randomized Control Clinical Trial Design	10.05.
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	09.05.
Earnings Flash (ACLX) ARCELLX Posts Q1 Revenue $39.3M	09.05.
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	09.05.
Arcellx Provides First Quarter 2024 Financial Results	09.05.
Arcellx to Participate in Two Upcoming Investor Conferences	07.05.
Arcellx Insider Sold Shares Worth $932,557, According to a Recent SEC Filing	03.05.
Arcellx Insider Sold Shares Worth $522,260, According to a Recent SEC Filing	18.04.
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference	04.04.
Arcellx Insider Sold Shares Worth $1,548,887, According to a Recent SEC Filing	03.04.
Arcellx Insider Sold Shares Worth $35,575,755, According to a Recent SEC Filing	25.03.
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	20.03.
Arcellx Insider Sold Shares Worth $633,582, According to a Recent SEC Filing	19.03.
Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference	29.02.
Arcellx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
Earnings Flash (ACLX) ARCELLX Posts Q4 Revenue $63.1M	28.02.
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights	28.02.
Arcellx, Inc. Enters an Assignment of Lease with A Third Party Sublessee	31.01.
Arcellx, Inc. Approves Relocation of the Headquarters	31.01.
Arcellx Insider Sold Shares Worth $419,926, According to a Recent SEC Filing	08.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Arcellx, Inc.

Aktien

A3DEJC

US03940C1009

ACLX

Andere Sprachen

Filter